These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 9500619)

  • 1. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
    De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
    Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
    Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
    Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
    Hale D; Gottschalk R; Maki T; Monaco AP
    Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
    Kanamoto A; Monaco AP; Maki T
    Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
    Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
    De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
    Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
    [No Abstract]   [Full Text] [Related]  

  • 14. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 15. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow.
    Anam K; Akpinar E; Craighead N; Black AT; Hale DA
    Transplantation; 2004 Nov; 78(9):1290-8. PubMed ID: 15548965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA; Chambers WH; Monaco AP; Maki T
    Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.